Clinical trial
Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal…
NCT00496509 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00496509 |
|---|---|
| Title | Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer |
| Official title | A Phase I, Open-Label Study To Assess The Effect of ZD6474 (ZACTIMA) On Vascular Permeability In Patients With Advanced Colorectal Cancer and Liver Metastases |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | ZD6474 (Zactima) 100mg, Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MR), Biomarker Draws, ZD6474 (Zactima) 300mg |
| Enrollment | 24 |
| Start date | Aug 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jul 4, 2007 |
| Last update posted | Aug 26, 2016 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: